产品名称 | NebuSelect™ Recombinant Mouse IL-17RB, His-tag |
---|---|
目录号 | NBL-241007 |
别名 | IL-17RB; IL-17 receptor B; IL-17RB; IL-17ER; Evi27; IL-17 RH1; IL-17ER; IL17RB |
外观 | see COA |
分子量 | Arg18-Gly286 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9JIP3-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241007-100ug | 100ug | Inquire | Inquire | |
NBL-241007-1mg | 1mg | Inquire | Inquire | |
NBL-241007-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse IL-17RB, His-tag
Catalog#:
NBL-241007
Description:
NebuSelect™ Recombinant Mouse IL-17RB, His-tag(Cat#NBL-241007) is expressed in HEK293 with His tag at the C-Terminus.It contains Arg18-Gly286.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 30.9 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
IL-17RB; IL-17 receptor B; IL-17RB; IL-17ER; Evi27; IL-17 RH1; IL-17ER; IL17RB
Target Information:
Among inflammatory mediators, a growing body of evidence emphasizes the contribution of the interleukin 17 (IL-17) cytokine family in malignant diseases. Besides IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. In mouse models, IL-17B signaling through IL-17RB directly promotes cancer cell survival, proliferation, and migration, and induces resistance to conventional chemotherapeutic agents.
Amino Acid Sequence:
Arg18-Gly286
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.